The researchers at the UNC Food Allergy Initiative are looking for children with cashew allergies to participate in a research study in Chapel Hill. Specifically, this study will see if an experimental treatment using cashew drops placed under the tongue (sublingual immunotherapy, SLIT) for approximately 18 months can increase the amount of cashew that can be eaten safely without symptoms. This is called desensitization.
We're inviting people receiving lumpectomies for breast cancer to take part in a study looking at skin discoloration after the use of Magtrace®, a tracer already used to map sentinel lymph nodes during breast surgery. This research aims to understand how often skin discoloration occurs and how it affects patients over time. Participation involves questionnaires and skin imaging.
Do you have protein in your urine and have had a kidney biopsy? You may be able to participate in a research study to test to see if a study drug can reduce the amount of protein in your urine.
Do you have cancer that has spread to your bones (high-risk bone metastases)? Is your cancer not causing any pain, or asymptomatic? If so, you may be able to take part in a research study comparing the standard approach with the standard approach plus radiation therapy to see if it's better at lowering bone metastases-related complications.
By joining, you'll share important health information in a secure research registry to help scientists: -Understand how the immune system reacts to food -Improve diagnosis and treatment -Develop prevention strategies and new therapies
Do you have advanced Stage III or IV Head and Neck Cancer? You might be able to join a research study. We are looking at new treatments compared to the usual care for your type of cancer.
Do you have Idiopathic Pulmonary Fibrosis (IPF)? You might be able to try a new pill called Ifetroban. We want to see if this medication can help with your symptoms and stop your lungs from getting worse. Compensation provided.
Do you have incurable, metastatic head and neck squamous cell carcinoma ? If so, you may be able to take part in a study to see if a new drug called Cisplatin is effective.
Help us improve resources for patients with rheumatic conditions! This is a brief, anonymous survey aimed to gather information about what additional resources you'd like to learn about from your rheumatology care team. Learning about your interest and priorities will inform future development of programs, resources, and tools to promote health.
Would you like to learn more about your body composition and resting metabolic rate? If you identify as Asian and are between 18-35 years old, you may be eligible to participate in a research study evaluating body composition and metabolic health in multiple Asian ethnicities.